Evidence method
Level · gp.fundamentals.capex_revenue_ratio
-0.04% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
CPIX · Jun 30, 2016
CUMBERLAND PHARMACEUTICALS INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001628280-16-018625General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-15.41% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
-16.78% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
66.38% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
84.42% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-1.42% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
9.15% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
3.15% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History61 statesSelf-history eligible
Sep 30, 20217/7 normalizedLevel 3Dec 31, 20218/8 normalizedLevel 3Mar 31, 20228/8 normalizedLevel 3Jun 30, 20228/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/8 normalizedLevel 3Mar 31, 20238/8 normalizedLevel 3Jun 30, 20238/8 normalizedLevel 3Sep 30, 20238/8 normalizedLevel 3Dec 31, 20238/8 normalizedLevel 3Mar 31, 20248/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/8 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20264/4 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 0.94%
- Current
- -0.04%
- Delta
- -0.98%
- Previous
- 7.73%
- Current
- -15.41%
- Delta
- -23.14%
- Previous
- -10.93%
- Current
- -16.78%
- Delta
- -5.85%
- Previous
- 52.65%
- Current
- 66.38%
- Delta
- 13.73%
- Previous
- 84.18%
- Current
- 84.42%
- Delta
- 0.24%
- Previous
- -6.47%
- Current
- -1.42%
- Delta
- 5.05%
- Previous
- 9.13%
- Current
- 9.15%
- Delta
- 0.02%
- Previous
- 2.26%
- Current
- 3.15%
- Delta
- 0.89%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · CPIX Fundamental State →Transitioned To · CPIX Fundamental State →Transitioned To · CPIX CAPEX_INTENSITY_DECREASED →Transitioned To · CPIX CASH_GENERATION_DECREASED →Transitioned To · CPIX GROWTH_DECREASED →Transitioned To · CPIX INVENTORY_PRESSURE_INCREASED →Transitioned To · CPIX MARGIN_INCREASED →Transitioned To · CPIX PROFITABILITY_INCREASED →Transitioned To · CPIX R_AND_D_INTENSITY_INCREASED →Transitioned To · CPIX SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.